Changes in chemokine and growth factor levels may be useful biomarkers for monitoring disease severity in COVID-19 patients; a pilot study

Overview of attention for article published in Frontiers in immunology, January 2024

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 4 X users

Citations

dimensions_citation: 1 Dimensions

Readers on

mendeley: 3 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 68,376 followers.

RT @FrontImmunol: New Research: Changes in chemokine and growth factor levels may be useful biomarkers for monitoring disease severity in C…

04 Jan 2024

Reply Repost Favourite

RT @FrontImmunol: New Research: Changes in chemokine and growth factor levels may be useful biomarkers for monitoring disease severity in C…

04 Jan 2024

Reply Repost Favourite

Changes in chemokine and growth factor levels- useful biomarkers for monitoring disease severity in COVID19; serum levels: MIP-1α, RANTES, Eotaxin, CTACK, GRO-α, IP-10, MIG, basic-FGF, HGF, SCGF-β, G-CSF, M-CSF, SCF, MIF, LIF, TRAIL were signif⬆️in COVID19

04 Jan 2024

Reply Repost Favourite

New Research: Changes in chemokine and growth factor levels may be useful biomarkers for monitoring disease severity in COVID-19 patients; a pilot study: Aim The aim of the present study was to assess differences in the serum levels of… https://t.co/4sijk

04 Jan 2024

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.